MM

Matthew Matt Callahan

Botanix Pharmaceuticals Ltd | Executive Director
Mr Callahan is a life sciences executive based in Philadelphia and a founder of Botanix. He has been the founding CEO or Executive Director of a number of ASX listed and private pharmaceutical and health tech companies, including iCeutica Inc, Churchill Pharmaceuticals LLC, Dimerix Biosciences Ltd, Orthocell Ltd, Respirion Pharmaceuticals Pty Ltd, Rumin8 Pty Ltd and Emyria Ltd. Mr Callahan has led the development and commercialization of several products that have received FDA and other global regulatory approvals, he has more than 25 years of industry, IP and legal experience.

Company and Role

Company
Title
Tenure
Since
BOT
Botanix Pharmaceuticals Ltd
  • Executive Director
5yrsFeb 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BOT
Botanix Pharmaceuticals Ltd
30/06/24N/A74,586,791N/AN/A
30/06/22N/A1,229,6222,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BOT
Botanix Pharmaceuticals Ltd
02/12/24
Issued
3,000,000$0.350$1,050,000Issue of securities
BOT
Botanix Pharmaceuticals Ltd
18/05/23
Exercise
1,166,667$0.085$99,166Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
18/05/23
Buy
1,166,667$0.085$99,166Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
20/03/23
Buy
1,166,666$0.097$113,166Conversion of securities
BOT
Botanix Pharmaceuticals Ltd
20/03/23
Exercise
1,166,666$0.097$113,166Conversion of securities